Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Ee6megsf04edmzauyd7wzoppmv8 v2mwbkteteejunl7afwpgczizabvng2zmglilhq78di x7defapnu4iaw5s04iyluwjpoexohittnc4aps  j0es53fro krog75dcf wcu

LELANTOS II Duchenne Muscular Dystrophy Study

Publication date: 11 Feb 2022

Associated community Muscular Dystrophy, Duchenne and Becker Types

You and your loved one are not alone in managing Duchenne muscular dystrophy. The LELANTOS II study is evaluating an investigational drug in patients with Duchenne muscular dystrophy who can walk without braces or assistive devices. The study is evaluating whether the drug can maintain or improve muscle strength of upper extremities and stabilize respiratory and heart functions in Duchenne patients.

Duchenne patients who fit the following criteria may be eligible to participate:

  • A Duchenne muscular dystrophy diagnosis

  • Male

  • 6-11 years old

  • Currently able to walk without braces or assistive devices

  • On a stable dose of corticosteroids for at least 6 months

Duchenne research can only move forward with volunteers. Answer a few questions to see if  your loved one is eligible to take part in this clinical study: http://

Thank you for your interest!

View link